Cargando…

Comment on: Atkinson. It's Time to Consider Changing the Rules: The Rationale for Rethinking Control Groups in Clinical Trials Aimed at Reversing Type 1 Diabetes. Diabetes 2011;60:361–363

Detalles Bibliográficos
Autores principales: Sanda, Srinath, Greenbaum, Carla J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3114381/
https://www.ncbi.nlm.nih.gov/pubmed/21617183
http://dx.doi.org/10.2337/db11-0253
_version_ 1782206057700917248
author Sanda, Srinath
Greenbaum, Carla J.
author_facet Sanda, Srinath
Greenbaum, Carla J.
author_sort Sanda, Srinath
collection PubMed
description
format Online
Article
Text
id pubmed-3114381
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-31143812012-06-01 Comment on: Atkinson. It's Time to Consider Changing the Rules: The Rationale for Rethinking Control Groups in Clinical Trials Aimed at Reversing Type 1 Diabetes. Diabetes 2011;60:361–363 Sanda, Srinath Greenbaum, Carla J. Diabetes Online Letters to the Editor American Diabetes Association 2011-06 2011-05-21 /pmc/articles/PMC3114381/ /pubmed/21617183 http://dx.doi.org/10.2337/db11-0253 Text en © 2011 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
spellingShingle Online Letters to the Editor
Sanda, Srinath
Greenbaum, Carla J.
Comment on: Atkinson. It's Time to Consider Changing the Rules: The Rationale for Rethinking Control Groups in Clinical Trials Aimed at Reversing Type 1 Diabetes. Diabetes 2011;60:361–363
title Comment on: Atkinson. It's Time to Consider Changing the Rules: The Rationale for Rethinking Control Groups in Clinical Trials Aimed at Reversing Type 1 Diabetes. Diabetes 2011;60:361–363
title_full Comment on: Atkinson. It's Time to Consider Changing the Rules: The Rationale for Rethinking Control Groups in Clinical Trials Aimed at Reversing Type 1 Diabetes. Diabetes 2011;60:361–363
title_fullStr Comment on: Atkinson. It's Time to Consider Changing the Rules: The Rationale for Rethinking Control Groups in Clinical Trials Aimed at Reversing Type 1 Diabetes. Diabetes 2011;60:361–363
title_full_unstemmed Comment on: Atkinson. It's Time to Consider Changing the Rules: The Rationale for Rethinking Control Groups in Clinical Trials Aimed at Reversing Type 1 Diabetes. Diabetes 2011;60:361–363
title_short Comment on: Atkinson. It's Time to Consider Changing the Rules: The Rationale for Rethinking Control Groups in Clinical Trials Aimed at Reversing Type 1 Diabetes. Diabetes 2011;60:361–363
title_sort comment on: atkinson. it's time to consider changing the rules: the rationale for rethinking control groups in clinical trials aimed at reversing type 1 diabetes. diabetes 2011;60:361–363
topic Online Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3114381/
https://www.ncbi.nlm.nih.gov/pubmed/21617183
http://dx.doi.org/10.2337/db11-0253
work_keys_str_mv AT sandasrinath commentonatkinsonitstimetoconsiderchangingtherulestherationaleforrethinkingcontrolgroupsinclinicaltrialsaimedatreversingtype1diabetesdiabetes201160361363
AT greenbaumcarlaj commentonatkinsonitstimetoconsiderchangingtherulestherationaleforrethinkingcontrolgroupsinclinicaltrialsaimedatreversingtype1diabetesdiabetes201160361363